- published: 15 Sep 2011
- views: 24766
Create your page here
-
remove the playlistAstrazeneca
-
remove the playlistLatest Videos
-
remove the playlistLongest Videos
- remove the playlistAstrazeneca
- remove the playlistLatest Videos
- remove the playlistLongest Videos
back to playlist
Learn from AstraZeneca’s students about the exciting opportunities our graduate programmes have to offer. Learn more about how you can join us: http://www.astrazenecacareers.com/students/
- published: 16 Sep 2015
- views: 1460
Listen to David Smoley, Chief Information Officer, AstraZeneca discuss how Box has enabled the company to reinforce its cloud strategy. Learn more about our customers here: box.com/customers
- published: 15 Sep 2015
- views: 2584
Astrazeneca Commercial 2016 Super Bowl Commercial. In this Super Bowl 50 commercial, a man nervously sits in a cafe drinking a coffee when he hears the toilet flush in the background. The word "Envy" flashes on screen, and a smiling man walks out of the bathroom.
Astrazeneca Commercial
Astrazeneca super bowl
Astrazeneca super bowl commercial
Astrazeneca super bowl ad
Astrazeneca super bowl 50
Astrazeneca super bowl 2016
Astrazeneca super bowl 2016 commercial
Astrazeneca super bowl commercial 2016
Astrazeneca super bowl 50 commercial
Astrazeneca ad
#Astrazeneca
#Commercial
#2016
#Super
#Bowl
#Commercial
https://www.youtube.com/channel/UCVPmZ9IrkSGUuCii7xPjiaQ
- published: 08 Feb 2016
- views: 1605
We push the boundaries of science to deliver life-changing medicines.
- published: 11 Dec 2014
- views: 6748
AstraZeneca today revealed the proposed designs for its new Global R&D; Centre and Corporate Headquarters in Cambridge in the UK. The plans for the new facility, which will be located on the Cambridge Biomedical Campus (CBC), include designs for the Global Centre, an R&D; Enabling Building and an Energy Centre. Read more at astrazeneca.com
- published: 18 Jul 2014
- views: 10262
Find out about the outlook for dividends, its drug pipeline and much more.
- published: 30 Oct 2015
- views: 2339
AstraZeneca Australia, is now relying on ABB robot technology to pack and palletise asthma medication to meet rising export demand. The ABB robots are part of an $80 million investment in six new production lines at AstraZeneca’s North Ryde facility in Sydney.
- published: 21 Dec 2015
- views: 2267
When leading global pharmaceutical company AstraZeneca decided to take a fresh look at what it meant to be an 'employer of choice' in its Australian operations in 2009, they went all out and decided to have a bit of fun in the process. They set out to create a strong culture of recognition across their remarkably diverse workforce and at the heart of their plans was a small blue mascot -- 'Charlie' -- who quickly became synonymous with recognition and reward. Four years on, he is still an immensely popular and recognisable figure across the organisation.
- published: 23 Feb 2014
- views: 2425
Watch to find out what attracted Dapo Ajayi, Chief Procurement Officer at AstraZeneca to her CPO role, her vision for the future of procurement and more. Plus, click here to search jobs by career area to view open procurement positions at AstraZeneca: http://bit.ly/1ySKWng
- published: 19 Nov 2014
- views: 2918
AstraZeneca plc (LSE: AZN, OMX: AZN) is a British multinational pharmaceutical and biologics company headquartered in London, United Kingdom. It is the world's fifth-largest pharmaceutical company measured by 2009 prescription drug sales (after Pfizer, Novartis, Sanofi and GlaxoSmithKline) and has operations in over 100 countries. It has a portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. The company was founded in 1999 through the merger of the Sweden-based Astra AB and UK-based Zeneca Group.
AstraZeneca has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. It had a market capitalisation of approximately £39.5 billion as of 23 December 2011, the 10th-largest of any company with a primary listing on the London Stock Exchange. It has secondary listings on the New York Stock Exchange and the OMX exchange.
Astra AB was founded in 1913 by 400 doctors and apothecaries in Södertälje, Sweden. In 1993 British ICI demerged its pharmaceuticals businesses and its agrochemicals and specialties businesses, to form Zeneca Group plc, and in 1999 Astra and Zeneca Group merged to form AstraZeneca plc.
This page contains text from Wikipedia, the Free Encyclopedia -
http://en.wikipedia.org/wiki/AstraZeneca
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
- Loading...
-
3:46The AstraZeneca story
The AstraZeneca story -
4:53AstraZeneca Graduate Programme
AstraZeneca Graduate ProgrammeAstraZeneca Graduate Programme
Learn from AstraZeneca’s students about the exciting opportunities our graduate programmes have to offer. Learn more about how you can join us: http://www.astrazenecacareers.com/students/ -
2:56AstraZeneca Employees use Box to Drive Change through Innovation
AstraZeneca Employees use Box to Drive Change through InnovationAstraZeneca Employees use Box to Drive Change through Innovation
Listen to David Smoley, Chief Information Officer, AstraZeneca discuss how Box has enabled the company to reinforce its cloud strategy. Learn more about our customers here: box.com/customers -
2:17Astrazeneca Commercial 2016 Super Bowl Commercial
Astrazeneca Commercial 2016 Super Bowl CommercialAstrazeneca Commercial 2016 Super Bowl Commercial
Astrazeneca Commercial 2016 Super Bowl Commercial. In this Super Bowl 50 commercial, a man nervously sits in a cafe drinking a coffee when he hears the toilet flush in the background. The word "Envy" flashes on screen, and a smiling man walks out of the bathroom. Astrazeneca Commercial Astrazeneca super bowl Astrazeneca super bowl commercial Astrazeneca super bowl ad Astrazeneca super bowl 50 Astrazeneca super bowl 2016 Astrazeneca super bowl 2016 commercial Astrazeneca super bowl commercial 2016 Astrazeneca super bowl 50 commercial Astrazeneca ad #Astrazeneca #Commercial #2016 #Super #Bowl #Commercial https://www.youtube.com/channel/UCVPmZ9IrkSGUuCii7xPjiaQ -
1:32AstraZeneca and MedImmune: Our Purpose
AstraZeneca and MedImmune: Our PurposeAstraZeneca and MedImmune: Our Purpose
We push the boundaries of science to deliver life-changing medicines. -
1:01AstraZeneca reveals designs for new Global R&D; Centre and Corporate Headquarters in Cambridge, UK
AstraZeneca reveals designs for new Global R&D; Centre and Corporate Headquarters in Cambridge, UKAstraZeneca reveals designs for new Global R&D; Centre and Corporate Headquarters in Cambridge, UK
AstraZeneca today revealed the proposed designs for its new Global R&D; Centre and Corporate Headquarters in Cambridge in the UK. The plans for the new facility, which will be located on the Cambridge Biomedical Campus (CBC), include designs for the Global Centre, an R&D; Enabling Building and an Energy Centre. Read more at astrazeneca.com -
11:53AstraZeneca - exclusive interview
AstraZeneca - exclusive interviewAstraZeneca - exclusive interview
Find out about the outlook for dividends, its drug pipeline and much more. -
4:01Unique ABB robot solution increases throughput at AstraZeneca Australia
Unique ABB robot solution increases throughput at AstraZeneca AustraliaUnique ABB robot solution increases throughput at AstraZeneca Australia
AstraZeneca Australia, is now relying on ABB robot technology to pack and palletise asthma medication to meet rising export demand. The ABB robots are part of an $80 million investment in six new production lines at AstraZeneca’s North Ryde facility in Sydney. -
3:56Employee Recognition at AstraZeneca
Employee Recognition at AstraZenecaEmployee Recognition at AstraZeneca
When leading global pharmaceutical company AstraZeneca decided to take a fresh look at what it meant to be an 'employer of choice' in its Australian operations in 2009, they went all out and decided to have a bit of fun in the process. They set out to create a strong culture of recognition across their remarkably diverse workforce and at the heart of their plans was a small blue mascot -- 'Charlie' -- who quickly became synonymous with recognition and reward. Four years on, he is still an immensely popular and recognisable figure across the organisation. -
3:45Dapo Ajayi - AstraZeneca Chief Procurement Officer
Dapo Ajayi - AstraZeneca Chief Procurement OfficerDapo Ajayi - AstraZeneca Chief Procurement Officer
Watch to find out what attracted Dapo Ajayi, Chief Procurement Officer at AstraZeneca to her CPO role, her vision for the future of procurement and more. Plus, click here to search jobs by career area to view open procurement positions at AstraZeneca: http://bit.ly/1ySKWng
- ABB Group
- ACE Limited
- Acme Markets
- Admiral Group
- Aggreko
- AGI-1067
- Agrochemicals
- AgustaWestland
- Airgas
- Alderley Park
- Alfa Laval
- Allegation
- Alliance Boots
- AlliedBarton
- AMEC
- AmerisourceBergen
- Anaesthetics
- Anastrozole
- Anglo American plc
- Annual report
- Antofagasta PLC
- Anxiety disorder
- Apothacary
- Aqua America
- Aramark
- ARM Holdings
- Ashland Inc.
- Ashmore Group
- Assa Abloy
- Astex
- Astra AB
- AstraZeneca
- Atenolol
- Atherosclerosis
- Atlas Copco
- Aviva
- BAE Systems
- Ballard Spahr
- Bambuterol
- Bandolier (journal)
- Barclays
- Beneficial Bank
- Bentley Systems
- BG Group
- BHP Billiton
- Bicalutamide
- Biotechnology
- Blackstone Group
- Blank Rome
- Blood vessel
- Boliden AB
- Boscov's
- BP
- British Land
- Brompheniramine
- BSkyB
- BT Group
- BTG
- Budesonide
- Bunzl
- Bupivacaine
- Burberry
- Business record
- Business Week
- Capita Group
- Cardiology
- Cardiovascular
- Category AstraZeneca
- Cediranib
- Cefotetan
- Centocor
- Centrica
- Cephalon
- Cheshire
- Chloroquine
- Chlortalidone
- Cigna
- Circulatory system
- Class action
- Clinical trial
- Clomethiazole
- Colonial Penn
- Comcast
- Compass Group
- Conseco
- Conspiracy (crime)
- Corporate title
- Cover story
- Cozen O'Connor
- CRH plc
- Croda International
- Crown Holdings
- Cyclacel
- Daptomycin
- Deceptive
- Dechert
- Delaware Valley
- Delmarva Power
- Demerged
- Diabetes
- Diageo
- Disufenton sodium
- Document
- Dow Chemical
- DrugScope
- Duane Morris
- DuPont
- Eastern Europe
- EBay
- Editor in chief
- Electrolux
- Enalapril
- Enantiomer
- Ericsson
- Esomeprazole
- Espionage
- Evraz
- Exelon
- Experian
- Felodipine
- FluMist
- Forman Mills
- Formoterol
- Fortune 500
- Foscarnet
- Fraud
- Fresnillo plc
- FTSE 100 Index
- Fulvestrant
- G4S
- Galida
- Gastroenterology
- Gastrointestinal
- GE Healthcare
- Gefitinib
- Generic drug
- Genus plc
- Getinge Group
- GKN
- GlaxoSmithKline
- Glencore
- Goserelin
- GSI Commerce
- H&M;
- Hammerson
- Handelsbanken
- Harald zur Hausen
- Hargreaves Lansdown
- Heart problems
- Hercules Inc.
- Hewlett-Packard
- HSBC
- HSBC Bank USA
- Hydrochlorothiazide
- ICAP (company)
- IMI plc
- Imperial Tobacco
- Infection
- Infectious disease
- Inflammation
- ING Group
- Intercytex
- International Power
- Intertek
- Investor AB
- ITV plc
- Johnson & Johnson
- Johnson Matthey
- Kazakhmys
- KGB
- Kingfisher plc
- Land Securities
- Lawsuit
- Lawsuits
- Legal & General
- Lexxel
- Liberty Media
- Lidocaine
- Lidocaine prilocaine
- Lisinopril
- Lloyds Banking Group
- Logimax
- Lundin Petroleum
- MAB Paints
- Madrid
- Man Group
- Marcia Angell
- Marks & Spencer
- McNeil Laboratories
- MedImmune
- Meggitt
- Mepivacaine
- Meropenem
- Metoprolol
- Modern Times Group
- Monk's Heath
- Morrisons
- Motavizumab
- Mölndal
- Naproxen
- National Grid plc
- Neoware
- Net income
- Neurology
- Neuroscience
- Next (clothing)
- Nif-Ten
- Nifedipine
- Nokia
- Nordea
- Norfloxacin
- Novartis
- OJSC Polymetal
- Old Mutual
- Omeprazole
- OMX
- OMX Stockholm 30
- Oncology
- OpenCorporates
- Oxford BioMedica
- Palivizumab
- Pearson PLC
- PECO Energy Company
- Pep Boys
- Pepco Holdings
- Pepper Hamilton
- Personal injury
- Petrofac
- Pfizer
- Pfizer UK
- Pharmaceuticals
- Philadelphia
- Phytopharm
- Pinnacle Foods
- Placebo
- Plead guilty
- Polish Water Ice
- Portal Companies
- Portal London
- Prilocaine
- Prilosec
- Primidone
- Product liability
- Proguanil
- Propofol
- Propranolol
- Prudential plc
- Psychiatry
- Pulmonology
- Quetiapine
- QVC
- Radian Group
- Raltitrexed
- Ramipril
- Randgold Resources
- Reckitt Benckiser
- Reed Elsevier
- Renovo plc
- Resolution Limited
- Respiratory system
- Rexam
- Rio Tinto Group
- Rita's Italian Ice
- Rohm and Haas
- Rolls-Royce plc
- Ropivacaine
- Rosuvastatin
- Royal Dutch Shell
- RSA Insurance Group
- SABMiller
- Safe
- Sage Group
- Sainsbury's
- Sandvik
- Sanofi
- SAP AG
- Saul Ewing
- Scania AB
- Schroders
- Securitas AB
- Seloken XL
- Serco Group
- Severn Trent
- Sexual harassment
- Sherwin-Williams
- Shire plc
- Side effects
- Sikorsky Aircraft
- Skanska
- SKF
- Smith & Nephew
- Smiths Group
- Social medicine
- Sovereign Bank
- Specialties
- SSAB
- SSE plc
- Standard Chartered
- Standard Life
- Stefan P. Kruszewski
- Stereoisomerism
- Stern (magazine)
- Stroke
- Subaru of America
- SunGard
- Sunoco
- Swedbank
- Sweden
- Swedish Match
- Södertälje
- Tamoxifen
- Tasty Baking Company
- Tate & Lyle
- TBS GB
- TD Bank, N.A.
- Tele2
- TeliaSonera
- Template AstraZeneca
- Tenoretic
- Terbutaline
- Tesco
- The New Yorker
- The Vanguard Group
- Thrombosis
- Ticagrelor
- Ticker symbol
- Tom McKillop
- Toprol-XL
- Tullow Oil
- U.S. District Court
- UGI Corporation
- Unilever
- Unimax
- Unipath
- Unisys
- United Kingdom
- United Utilities
- Urban Outfitters
- Vandetanib
- Vectura Group
- Vedanta Resources
- Vernalis plc
- ViiV Healthcare
- Viloxazine
- ViroPharma
- Vodafone
- Volvo
- Wawa Food Market
- Weight gain
- Weir Group
- Whitbread
- Wikipedia Link rot
- Wilmington Trust
- Wolseley plc
- WPP plc
- WSFS Bank
- Ximelagatran
- Xstrata
- Xyloproct
- Yacht
- Yahoo!
- Zafirlukast
- Zeneca
- Zestoretic
- Zolmitriptan
-
-
AstraZeneca Graduate Programme
Learn from AstraZeneca’s students about the exciting opportunities our graduate programmes have to offer. Learn more about how you can join us: http://www.astrazenecacareers.com/students/ -
AstraZeneca Employees use Box to Drive Change through Innovation
Listen to David Smoley, Chief Information Officer, AstraZeneca discuss how Box has enabled the company to reinforce its cloud strategy. Learn more about our customers here: box.com/customers -
Astrazeneca Commercial 2016 Super Bowl Commercial
Astrazeneca Commercial 2016 Super Bowl Commercial. In this Super Bowl 50 commercial, a man nervously sits in a cafe drinking a coffee when he hears the toilet flush in the background. The word "Envy" flashes on screen, and a smiling man walks out of the bathroom. Astrazeneca Commercial Astrazeneca super bowl Astrazeneca super bowl commercial Astrazeneca super bowl ad Astrazeneca super bowl 50 Astrazeneca super bowl 2016 Astrazeneca super bowl 2016 commercial Astrazeneca super bowl commercial 2016 Astrazeneca super bowl 50 commercial Astrazeneca ad #Astrazeneca #Commercial #2016 #Super #Bowl #Commercial https://www.youtube.com/channel/UCVPmZ9IrkSGUuCii7xPjiaQ -
AstraZeneca and MedImmune: Our Purpose
We push the boundaries of science to deliver life-changing medicines. -
AstraZeneca reveals designs for new Global R&D; Centre and Corporate Headquarters in Cambridge, UK
AstraZeneca today revealed the proposed designs for its new Global R&D; Centre and Corporate Headquarters in Cambridge in the UK. The plans for the new facility, which will be located on the Cambridge Biomedical Campus (CBC), include designs for the Global Centre, an R&D; Enabling Building and an Energy Centre. Read more at astrazeneca.com -
AstraZeneca - exclusive interview
Find out about the outlook for dividends, its drug pipeline and much more. -
Unique ABB robot solution increases throughput at AstraZeneca Australia
AstraZeneca Australia, is now relying on ABB robot technology to pack and palletise asthma medication to meet rising export demand. The ABB robots are part of an $80 million investment in six new production lines at AstraZeneca’s North Ryde facility in Sydney. -
Employee Recognition at AstraZeneca
When leading global pharmaceutical company AstraZeneca decided to take a fresh look at what it meant to be an 'employer of choice' in its Australian operations in 2009, they went all out and decided to have a bit of fun in the process. They set out to create a strong culture of recognition across their remarkably diverse workforce and at the heart of their plans was a small blue mascot -- 'Charlie' -- who quickly became synonymous with recognition and reward. Four years on, he is still an immensely popular and recognisable figure across the organisation. -
Dapo Ajayi - AstraZeneca Chief Procurement Officer
Watch to find out what attracted Dapo Ajayi, Chief Procurement Officer at AstraZeneca to her CPO role, her vision for the future of procurement and more. Plus, click here to search jobs by career area to view open procurement positions at AstraZeneca: http://bit.ly/1ySKWng
The AstraZeneca story
- Order: Reorder
- Duration: 3:46
- Updated: 15 Sep 2011
- views: 24766
Hear from our employees about AstraZeneca -- who we are, what we do and how we do it. Read more: http://www.astrazeneca.com/About-Us/Features
Hear from our employees about AstraZeneca -- who we are, what we do and how we do it. Read more: http://www.astrazeneca.com/About-Us/Features
wn.com/The Astrazeneca Story
AstraZeneca Graduate Programme
- Order: Reorder
- Duration: 4:53
- Updated: 16 Sep 2015
- views: 1460
Learn from AstraZeneca’s students about the exciting opportunities our graduate programmes have to offer. Learn more about how you can join us: http://www.astra...
Learn from AstraZeneca’s students about the exciting opportunities our graduate programmes have to offer. Learn more about how you can join us: http://www.astrazenecacareers.com/students/
wn.com/Astrazeneca Graduate Programme
Learn from AstraZeneca’s students about the exciting opportunities our graduate programmes have to offer. Learn more about how you can join us: http://www.astrazenecacareers.com/students/
- published: 16 Sep 2015
- views: 1460
AstraZeneca Employees use Box to Drive Change through Innovation
- Order: Reorder
- Duration: 2:56
- Updated: 15 Sep 2015
- views: 2584
Listen to David Smoley, Chief Information Officer, AstraZeneca discuss how Box has enabled the company to reinforce its cloud strategy. Learn more about our cus...
Listen to David Smoley, Chief Information Officer, AstraZeneca discuss how Box has enabled the company to reinforce its cloud strategy. Learn more about our customers here: box.com/customers
wn.com/Astrazeneca Employees Use Box To Drive Change Through Innovation
Listen to David Smoley, Chief Information Officer, AstraZeneca discuss how Box has enabled the company to reinforce its cloud strategy. Learn more about our customers here: box.com/customers
- published: 15 Sep 2015
- views: 2584
Astrazeneca Commercial 2016 Super Bowl Commercial
- Order: Reorder
- Duration: 2:17
- Updated: 08 Feb 2016
- views: 1605
Astrazeneca Commercial 2016 Super Bowl Commercial. In this Super Bowl 50 commercial, a man nervously sits in a cafe drinking a coffee when he hears the toilet f...
Astrazeneca Commercial 2016 Super Bowl Commercial. In this Super Bowl 50 commercial, a man nervously sits in a cafe drinking a coffee when he hears the toilet flush in the background. The word "Envy" flashes on screen, and a smiling man walks out of the bathroom.
Astrazeneca Commercial
Astrazeneca super bowl
Astrazeneca super bowl commercial
Astrazeneca super bowl ad
Astrazeneca super bowl 50
Astrazeneca super bowl 2016
Astrazeneca super bowl 2016 commercial
Astrazeneca super bowl commercial 2016
Astrazeneca super bowl 50 commercial
Astrazeneca ad
#Astrazeneca
#Commercial
#2016
#Super
#Bowl
#Commercial
https://www.youtube.com/channel/UCVPmZ9IrkSGUuCii7xPjiaQ
wn.com/Astrazeneca Commercial 2016 Super Bowl Commercial
Astrazeneca Commercial 2016 Super Bowl Commercial. In this Super Bowl 50 commercial, a man nervously sits in a cafe drinking a coffee when he hears the toilet flush in the background. The word "Envy" flashes on screen, and a smiling man walks out of the bathroom.
Astrazeneca Commercial
Astrazeneca super bowl
Astrazeneca super bowl commercial
Astrazeneca super bowl ad
Astrazeneca super bowl 50
Astrazeneca super bowl 2016
Astrazeneca super bowl 2016 commercial
Astrazeneca super bowl commercial 2016
Astrazeneca super bowl 50 commercial
Astrazeneca ad
#Astrazeneca
#Commercial
#2016
#Super
#Bowl
#Commercial
https://www.youtube.com/channel/UCVPmZ9IrkSGUuCii7xPjiaQ
- published: 08 Feb 2016
- views: 1605
AstraZeneca and MedImmune: Our Purpose
- Order: Reorder
- Duration: 1:32
- Updated: 11 Dec 2014
- views: 6748
We push the boundaries of science to deliver life-changing medicines.
We push the boundaries of science to deliver life-changing medicines.
wn.com/Astrazeneca And Medimmune Our Purpose
We push the boundaries of science to deliver life-changing medicines.
- published: 11 Dec 2014
- views: 6748
AstraZeneca reveals designs for new Global R&D; Centre and Corporate Headquarters in Cambridge, UK
- Order: Reorder
- Duration: 1:01
- Updated: 18 Jul 2014
- views: 10262
AstraZeneca today revealed the proposed designs for its new Global R&D; Centre and Corporate Headquarters in Cambridge in the UK. The plans for the new facility,...
AstraZeneca today revealed the proposed designs for its new Global R&D; Centre and Corporate Headquarters in Cambridge in the UK. The plans for the new facility, which will be located on the Cambridge Biomedical Campus (CBC), include designs for the Global Centre, an R&D; Enabling Building and an Energy Centre. Read more at astrazeneca.com
wn.com/Astrazeneca Reveals Designs For New Global R D Centre And Corporate Headquarters In Cambridge, UK
AstraZeneca today revealed the proposed designs for its new Global R&D; Centre and Corporate Headquarters in Cambridge in the UK. The plans for the new facility, which will be located on the Cambridge Biomedical Campus (CBC), include designs for the Global Centre, an R&D; Enabling Building and an Energy Centre. Read more at astrazeneca.com
- published: 18 Jul 2014
- views: 10262
AstraZeneca - exclusive interview
- Order: Reorder
- Duration: 11:53
- Updated: 30 Oct 2015
- views: 2339
Find out about the outlook for dividends, its drug pipeline and much more.
Find out about the outlook for dividends, its drug pipeline and much more.
wn.com/Astrazeneca Exclusive Interview
Find out about the outlook for dividends, its drug pipeline and much more.
- published: 30 Oct 2015
- views: 2339
Unique ABB robot solution increases throughput at AstraZeneca Australia
- Order: Reorder
- Duration: 4:01
- Updated: 21 Dec 2015
- views: 2267
AstraZeneca Australia, is now relying on ABB robot technology to pack and palletise asthma medication to meet rising export demand. The ABB robots are part of a...
AstraZeneca Australia, is now relying on ABB robot technology to pack and palletise asthma medication to meet rising export demand. The ABB robots are part of an $80 million investment in six new production lines at AstraZeneca’s North Ryde facility in Sydney.
wn.com/Unique Abb Robot Solution Increases Throughput At Astrazeneca Australia
AstraZeneca Australia, is now relying on ABB robot technology to pack and palletise asthma medication to meet rising export demand. The ABB robots are part of an $80 million investment in six new production lines at AstraZeneca’s North Ryde facility in Sydney.
- published: 21 Dec 2015
- views: 2267
Employee Recognition at AstraZeneca
- Order: Reorder
- Duration: 3:56
- Updated: 23 Feb 2014
- views: 2425
When leading global pharmaceutical company AstraZeneca decided to take a fresh look at what it meant to be an 'employer of choice' in its Australian operations...
When leading global pharmaceutical company AstraZeneca decided to take a fresh look at what it meant to be an 'employer of choice' in its Australian operations in 2009, they went all out and decided to have a bit of fun in the process. They set out to create a strong culture of recognition across their remarkably diverse workforce and at the heart of their plans was a small blue mascot -- 'Charlie' -- who quickly became synonymous with recognition and reward. Four years on, he is still an immensely popular and recognisable figure across the organisation.
wn.com/Employee Recognition At Astrazeneca
When leading global pharmaceutical company AstraZeneca decided to take a fresh look at what it meant to be an 'employer of choice' in its Australian operations in 2009, they went all out and decided to have a bit of fun in the process. They set out to create a strong culture of recognition across their remarkably diverse workforce and at the heart of their plans was a small blue mascot -- 'Charlie' -- who quickly became synonymous with recognition and reward. Four years on, he is still an immensely popular and recognisable figure across the organisation.
- published: 23 Feb 2014
- views: 2425
Dapo Ajayi - AstraZeneca Chief Procurement Officer
- Order: Reorder
- Duration: 3:45
- Updated: 19 Nov 2014
- views: 2918
Watch to find out what attracted Dapo Ajayi, Chief Procurement Officer at AstraZeneca to her CPO role, her vision for the future of procurement and more. Plus, ...
Watch to find out what attracted Dapo Ajayi, Chief Procurement Officer at AstraZeneca to her CPO role, her vision for the future of procurement and more. Plus, click here to search jobs by career area to view open procurement positions at AstraZeneca: http://bit.ly/1ySKWng
wn.com/Dapo Ajayi Astrazeneca Chief Procurement Officer
Watch to find out what attracted Dapo Ajayi, Chief Procurement Officer at AstraZeneca to her CPO role, her vision for the future of procurement and more. Plus, click here to search jobs by career area to view open procurement positions at AstraZeneca: http://bit.ly/1ySKWng
- published: 19 Nov 2014
- views: 2918
-
-
AstraZeneca CI360 (Competitive Intelligence 360) Wins Bio-IT World 2016 Best Practice Award
AstraZeneca CI360 (Competitive Intelligence 360) Wins Bio-IT World 2016 Best Practice Award for Knowledge Management. An interview at Bio-IT World Conference & Expo with AstraZeneca’s US Cross-Science Director of R&D; Information, Tom Plasterer, on CI360. To learn more about the event, visit http://www.bio-itworldexpo.com -
AstraZeneca Presents Full Slate of Studies at ADA
With more than 60 presentations at the American Diabetes Association's meeting AstraZeneca showed a wide range of studies all geared towards helping patients with this condition. -
Bourse - Action AstraZeneca, rebond anticipé - IG 16.06.2016
Suivez IG sur les réseaux sociaux : - Twitter : https://twitter.com/IG_France_ - Facebook : https://www.facebook.com/IGFrance -
AstraZeneca | 'What Science Can Do'
We worked directly with AstraZeneca to produce a series of award winning content for their successful major global re-brand. The films speak to an international market. We filmed across four continents and produced material in eight languages. The Silverfish Effect: Our style of working collaboratively with the AstraZeneca team enabled us to capture the very essence of a complex industry. Our creative production included devising animation sequences and brand assets to deliver a complete film-led package, which marked a new direction for the company. -
Aspen, AstraZeneca ink R7BN deal
Aspen CEO Stephen Saad speaks to Alishia Seckam and Stephen Gunnion about the group’s R7 billion deal with AstraZeneca that will add seven established medicines in 100 countries to the group’s portfolio; -
Pfizer and AstraZeneca: Marketing an Acquisition (A) Case Solutions
http://www.thecasesolutions.com/ This case is about Pfizer and AstraZeneca: Marketing an Acquisition Get your Pfizer and AstraZeneca: Marketing an Acquisition Case Solutions at TheCaseSolutions. Com THECASESOLUTIONS.COM is the number 1 destination for getting the case studies analyzed. http://www.thecasesolutions.com/pfizer-and-astrazeneca-marketing-an-acquisition-a-2-32565 -
-
-
Интерактивный сенсорный стол для AstraZeneca
- Order: Reorder
- Duration: 0:50
- Updated: 21 Jun 2016
- views: 17
С помощью игровых механик и трехмерной графики мы наглядно продемонстрировали преимущества препаратов компании AstraZeneca в борьбе с раком.
XIX Российский онк...
С помощью игровых механик и трехмерной графики мы наглядно продемонстрировали преимущества препаратов компании AstraZeneca в борьбе с раком.
XIX Российский онкологический конгресс, Москва, ноябрь 2015.
wn.com/Интерактивный Сенсорный Стол Для Astrazeneca
AstraZeneca CI360 (Competitive Intelligence 360) Wins Bio-IT World 2016 Best Practice Award
- Order: Reorder
- Duration: 1:19
- Updated: 20 Jun 2016
- views: 2
AstraZeneca CI360 (Competitive Intelligence 360) Wins Bio-IT World 2016 Best Practice Award for Knowledge Management.
An interview at Bio-IT World Conference & ...
AstraZeneca CI360 (Competitive Intelligence 360) Wins Bio-IT World 2016 Best Practice Award for Knowledge Management.
An interview at Bio-IT World Conference & Expo with AstraZeneca’s US Cross-Science Director of R&D; Information, Tom Plasterer, on CI360. To learn more about the event, visit http://www.bio-itworldexpo.com
wn.com/Astrazeneca Ci360 (Competitive Intelligence 360) Wins Bio It World 2016 Best Practice Award
AstraZeneca CI360 (Competitive Intelligence 360) Wins Bio-IT World 2016 Best Practice Award for Knowledge Management.
An interview at Bio-IT World Conference & Expo with AstraZeneca’s US Cross-Science Director of R&D; Information, Tom Plasterer, on CI360. To learn more about the event, visit http://www.bio-itworldexpo.com
- published: 20 Jun 2016
- views: 2
AstraZeneca Presents Full Slate of Studies at ADA
- Order: Reorder
- Duration: 5:02
- Updated: 17 Jun 2016
- views: 7
With more than 60 presentations at the American Diabetes Association's meeting AstraZeneca showed a wide range of studies all geared towards helping patients wi...
With more than 60 presentations at the American Diabetes Association's meeting AstraZeneca showed a wide range of studies all geared towards helping patients with this condition.
wn.com/Astrazeneca Presents Full Slate Of Studies At Ada
With more than 60 presentations at the American Diabetes Association's meeting AstraZeneca showed a wide range of studies all geared towards helping patients with this condition.
- published: 17 Jun 2016
- views: 7
Bourse - Action AstraZeneca, rebond anticipé - IG 16.06.2016
- Order: Reorder
- Duration: 0:46
- Updated: 16 Jun 2016
- views: 10
Suivez IG sur les réseaux sociaux :
- Twitter : https://twitter.com/IG_France_
- Facebook : https://www.facebook.com/IGFrance
Suivez IG sur les réseaux sociaux :
- Twitter : https://twitter.com/IG_France_
- Facebook : https://www.facebook.com/IGFrance
wn.com/Bourse Action Astrazeneca, Rebond Anticipé Ig 16.06.2016
Suivez IG sur les réseaux sociaux :
- Twitter : https://twitter.com/IG_France_
- Facebook : https://www.facebook.com/IGFrance
- published: 16 Jun 2016
- views: 10
AstraZeneca | 'What Science Can Do'
- Order: Reorder
- Duration: 2:45
- Updated: 13 Jun 2016
- views: 3
We worked directly with AstraZeneca to produce a series of award winning content for their successful major global re-brand. The films speak to an international...
We worked directly with AstraZeneca to produce a series of award winning content for their successful major global re-brand. The films speak to an international market. We filmed across four continents and produced material in eight languages.
The Silverfish Effect: Our style of working collaboratively with the AstraZeneca team enabled us to capture the very essence of a complex industry.
Our creative production included devising animation sequences and brand assets to deliver a complete film-led package, which marked a new direction for the company.
wn.com/Astrazeneca | 'What Science Can Do'
We worked directly with AstraZeneca to produce a series of award winning content for their successful major global re-brand. The films speak to an international market. We filmed across four continents and produced material in eight languages.
The Silverfish Effect: Our style of working collaboratively with the AstraZeneca team enabled us to capture the very essence of a complex industry.
Our creative production included devising animation sequences and brand assets to deliver a complete film-led package, which marked a new direction for the company.
- published: 13 Jun 2016
- views: 3
Aspen, AstraZeneca ink R7BN deal
- Order: Reorder
- Duration: 8:19
- Updated: 10 Jun 2016
- views: 82
Aspen CEO Stephen Saad speaks to Alishia Seckam and Stephen Gunnion about the group’s R7 billion deal with AstraZeneca that will add seven established medicines...
Aspen CEO Stephen Saad speaks to Alishia Seckam and Stephen Gunnion about the group’s R7 billion deal with AstraZeneca that will add seven established medicines in 100 countries to the group’s portfolio;
wn.com/Aspen, Astrazeneca Ink R7Bn Deal
Aspen CEO Stephen Saad speaks to Alishia Seckam and Stephen Gunnion about the group’s R7 billion deal with AstraZeneca that will add seven established medicines in 100 countries to the group’s portfolio;
- published: 10 Jun 2016
- views: 82
Pfizer and AstraZeneca: Marketing an Acquisition (A) Case Solutions
- Order: Reorder
- Duration: 1:03
- Updated: 09 Jun 2016
- views: 1
http://www.thecasesolutions.com/
This case is about Pfizer and AstraZeneca: Marketing an Acquisition
Get your Pfizer and AstraZeneca: Marketing an Acquisition...
http://www.thecasesolutions.com/
This case is about Pfizer and AstraZeneca: Marketing an Acquisition
Get your Pfizer and AstraZeneca: Marketing an Acquisition Case Solutions at TheCaseSolutions. Com
THECASESOLUTIONS.COM is the number 1 destination for getting the case studies analyzed.
http://www.thecasesolutions.com/pfizer-and-astrazeneca-marketing-an-acquisition-a-2-32565
wn.com/Pfizer And Astrazeneca Marketing An Acquisition (A) Case Solutions
http://www.thecasesolutions.com/
This case is about Pfizer and AstraZeneca: Marketing an Acquisition
Get your Pfizer and AstraZeneca: Marketing an Acquisition Case Solutions at TheCaseSolutions. Com
THECASESOLUTIONS.COM is the number 1 destination for getting the case studies analyzed.
http://www.thecasesolutions.com/pfizer-and-astrazeneca-marketing-an-acquisition-a-2-32565
- published: 09 Jun 2016
- views: 1
Tshirt review -LAST CHANCE - I CANT KEEP CALM, I WORK AT ASTRAZENECA PHARMACEUTICALS
- Order: Reorder
- Duration: 2:10
- Updated: 08 Jun 2016
- views: 0
LAST CHANCE - I CANT KEEP CALM, I WORK AT ASTRAZENECA PHARMACEUTICALS
CLICK HERE TO GET IT : http://tisfinger.com/ja6te
LAST CHANCE - I CANT KEEP CALM, I WORK AT ASTRAZENECA PHARMACEUTICALS
CLICK HERE TO GET IT : http://tisfinger.com/ja6te
wn.com/Tshirt Review Last Chance I Cant Keep Calm, I Work At Astrazeneca Pharmaceuticals
AstraZeneca at ASCO16
- Order: Reorder
- Duration: 3:25
- Updated: 06 Jun 2016
- views: 11
AstraZeneca's Susan Galbraith, head of the oncology innovative medicines unit talks about key AstraZeneca abstracts being presented at ASCO 2016.
AstraZeneca's Susan Galbraith, head of the oncology innovative medicines unit talks about key AstraZeneca abstracts being presented at ASCO 2016.
wn.com/Astrazeneca At Asco16
The Delaware Way AstraZeneca Billion Dollar Payroll Cuts
- Order: Reorder
- Duration: 5:01
- Updated: 06 Jun 2016
- views: 58
John Boyd Jr. is on to talk about Delaware's big name, AstraZeneca, and the Billion Dollars in Payroll Cuts.
John Boyd Jr. is on to talk about Delaware's big name, AstraZeneca, and the Billion Dollars in Payroll Cuts.
wn.com/The Delaware Way Astrazeneca Billion Dollar Payroll Cuts
-
Decision Making in Early Clinical Development - Paul Frewer, AstraZeneca
East® User Group Meeting 2016 Featured Presentation Paul Frewer, from the AZ Early Clinical Development, Biometrics department, reveals how AstraZeneca is realizing a more consistent approach to quantitative decision-making for all early phase investment decisions. The outcome is that early phase studies are designed mindful of the decision with study results interpreted against the pre-agreed decision framework, thereby streamlining the analysis and conclusions process. See all the EUGM 2016 presentation replays at: https://www.youtube.com/watch?v=gLFV4omj8qA&list;=PL1fvZeUGYHvk7mZ-IcBi8546a8MbDpddS -
Jay Greenspan Keynote Speech at AstraZeneca Global Safety Awards Banquet
Jay Greenspan Keynote Speech at AstraZeneca Global Engineering Americas Contractor Safety Awards Banquet - 17 March 2016 on Safety Leadership and his personal experiences. Please visit www.JMJ.com to learn more. Follow us on LinkedIn at http://www.linkedin.com/groups/66964 -
GuruTalk with Mr.Pankaj Gursahani, Director - Sales Training, AstraZeneca India Pharma Ltd.
The Business Code of Conduct - Join AVAGMAH Online Schools ongoing GuruTalk series to learn how to run businesses ethically from Mr. Pankaj Gursahani, Director-Sales Training, AstraZeneca India Pharma Ltd. -
AstraZeneca BioVentureHub Mölndal - Life Science-dagen 2016
AstraZeneca BioVentureHub i Mölndal presenteras av Magnus Björsne. Life Science-dagen anordnas av InWest Corporate Finance och Finwire. http://www.lifesciencedagen.se/ -
Professor Jackie Hunter: AstraZeneca Women in Pharmacology Prize
Professor Jackie Hunter from the Biotechnology and Biological Sciences Research Council, UK won the 2015 AstraZeneca Women in Pharmacology Prize. Her prize lecture was presented at Pharmacology 2015 - https://www.bps.ac.uk/news-events/future-scientific-meetings/2015/pharmacology-2015 -
¿Cómo crecer en una empresa? Entrevista a Sofía Videla, HR Director AstraZeneca
¿De quién es la responsabilidad por el desarrollo profesional?¿Qué es más importante: crecer o aprender? Entrevista a Sofía Videla, Directora de RRHH de AstraZeneca -
Professor Sussan Nourshargh, AstraZeneca Women in Pharmacology Lecture 2014
Professor Sussan Nourshargh, Queen Mary University of London, delivered the AstraZeneca Women in Pharmacology Prize Lecture 2014: Breaching barriers: Junctures and junctions in inflammation at Pharmacology 2014 -
OMXS30 SP500 Kinnevik AstraZeneca Husqvarna.avi
De amerikanska börserna tuffar på och måndagens positiva reversalformation stärkte köparna under gårdagen. Även om uppgångarna var måttliga på Dow Jones och S&P; 500 steg Nasdaq desto mer (tilltagande riskaptit). DJIA stängde igår över magiska 13.000 och S&P; 500 tog sig över 1371 som var taket för den motståndsnivå jag bevakat under några veckor. På ovansidan bevakar jag nu 1385-1396 från början av 2008 och därefter 1440 från den 19 maj 2008. På nedsidan bevakar jag utbrottsnivån 1371 följt av den korta sentimentnivån som MA-20 ger oss vid 1350. Därefter är det stödet vid 1300 följt av golvet i den stigande kanalen som inför dagen noteras kring 1277 som är intressant. OMXS30 var i måndags nere och testade 20-dagars medelvärde för andra gången sedan den 20 december. Även denna gång stod m... -
Professor Julia Buckingham, AstraZeneca Women in Pharmacology Prize Lecture 2009
Professor Julia Buckingham delivers the AstraZeneca Women in Pharmacology Prize Lecture 2009: Stress, laughter and a following wind. -
FIPH Account 2014 05 16 Pfizer & AstraZeneca
FIPH Account. Inversión Fundamental en Industria Farmacéutica y sector Health. Información e inversión bursatil, opiniones y formación continuada. FIPH Account. Investment by Fundamental Analysis in pharmaceutical industry and Sector Health. Information and stock, opinions and training investmnet.
Decision Making in Early Clinical Development - Paul Frewer, AstraZeneca
- Order: Reorder
- Duration: 47:16
- Updated: 27 Mar 2016
- views: 123
East® User Group Meeting 2016 Featured Presentation
Paul Frewer, from the AZ Early Clinical Development, Biometrics department, reveals how AstraZeneca is reali...
East® User Group Meeting 2016 Featured Presentation
Paul Frewer, from the AZ Early Clinical Development, Biometrics department, reveals how AstraZeneca is realizing a more consistent approach to quantitative decision-making for all early phase investment decisions. The outcome is that early phase studies are designed mindful of the decision with study results interpreted against the pre-agreed decision framework, thereby streamlining the analysis and conclusions process.
See all the EUGM 2016 presentation replays at:
https://www.youtube.com/watch?v=gLFV4omj8qA&list;=PL1fvZeUGYHvk7mZ-IcBi8546a8MbDpddS
wn.com/Decision Making In Early Clinical Development Paul Frewer, Astrazeneca
East® User Group Meeting 2016 Featured Presentation
Paul Frewer, from the AZ Early Clinical Development, Biometrics department, reveals how AstraZeneca is realizing a more consistent approach to quantitative decision-making for all early phase investment decisions. The outcome is that early phase studies are designed mindful of the decision with study results interpreted against the pre-agreed decision framework, thereby streamlining the analysis and conclusions process.
See all the EUGM 2016 presentation replays at:
https://www.youtube.com/watch?v=gLFV4omj8qA&list;=PL1fvZeUGYHvk7mZ-IcBi8546a8MbDpddS
- published: 27 Mar 2016
- views: 123
Jay Greenspan Keynote Speech at AstraZeneca Global Safety Awards Banquet
- Order: Reorder
- Duration: 49:24
- Updated: 25 May 2016
- views: 99
Jay Greenspan Keynote Speech at AstraZeneca Global Engineering Americas Contractor Safety Awards Banquet - 17 March 2016 on Safety Leadership and his personal e...
Jay Greenspan Keynote Speech at AstraZeneca Global Engineering Americas Contractor Safety Awards Banquet - 17 March 2016 on Safety Leadership and his personal experiences. Please visit www.JMJ.com to learn more.
Follow us on LinkedIn at http://www.linkedin.com/groups/66964
wn.com/Jay Greenspan Keynote Speech At Astrazeneca Global Safety Awards Banquet
Jay Greenspan Keynote Speech at AstraZeneca Global Engineering Americas Contractor Safety Awards Banquet - 17 March 2016 on Safety Leadership and his personal experiences. Please visit www.JMJ.com to learn more.
Follow us on LinkedIn at http://www.linkedin.com/groups/66964
- published: 25 May 2016
- views: 99
GuruTalk with Mr.Pankaj Gursahani, Director - Sales Training, AstraZeneca India Pharma Ltd.
- Order: Reorder
- Duration: 71:30
- Updated: 22 Oct 2013
- views: 1265
The Business Code of Conduct - Join AVAGMAH Online Schools ongoing GuruTalk series to learn how to run businesses ethically from Mr. Pankaj Gursahani, Director...
The Business Code of Conduct - Join AVAGMAH Online Schools ongoing GuruTalk series to learn how to run businesses ethically from Mr. Pankaj Gursahani, Director-Sales Training, AstraZeneca India Pharma Ltd.
wn.com/Gurutalk With Mr.Pankaj Gursahani, Director Sales Training, Astrazeneca India Pharma Ltd.
The Business Code of Conduct - Join AVAGMAH Online Schools ongoing GuruTalk series to learn how to run businesses ethically from Mr. Pankaj Gursahani, Director-Sales Training, AstraZeneca India Pharma Ltd.
- published: 22 Oct 2013
- views: 1265
AstraZeneca BioVentureHub Mölndal - Life Science-dagen 2016
- Order: Reorder
- Duration: 29:38
- Updated: 12 Mar 2016
- views: 34
AstraZeneca BioVentureHub i Mölndal presenteras av Magnus Björsne.
Life Science-dagen anordnas av InWest Corporate Finance och Finwire.
http://www.lifescience...
AstraZeneca BioVentureHub i Mölndal presenteras av Magnus Björsne.
Life Science-dagen anordnas av InWest Corporate Finance och Finwire.
http://www.lifesciencedagen.se/
wn.com/Astrazeneca Bioventurehub MöLndal Life Science Dagen 2016
AstraZeneca BioVentureHub i Mölndal presenteras av Magnus Björsne.
Life Science-dagen anordnas av InWest Corporate Finance och Finwire.
http://www.lifesciencedagen.se/
- published: 12 Mar 2016
- views: 34
Professor Jackie Hunter: AstraZeneca Women in Pharmacology Prize
- Order: Reorder
- Duration: 40:55
- Updated: 17 Feb 2016
- views: 81
Professor Jackie Hunter from the Biotechnology and Biological Sciences Research Council, UK won the 2015 AstraZeneca Women in Pharmacology Prize. Her prize lect...
Professor Jackie Hunter from the Biotechnology and Biological Sciences Research Council, UK won the 2015 AstraZeneca Women in Pharmacology Prize. Her prize lecture was presented at Pharmacology 2015 - https://www.bps.ac.uk/news-events/future-scientific-meetings/2015/pharmacology-2015
wn.com/Professor Jackie Hunter Astrazeneca Women In Pharmacology Prize
Professor Jackie Hunter from the Biotechnology and Biological Sciences Research Council, UK won the 2015 AstraZeneca Women in Pharmacology Prize. Her prize lecture was presented at Pharmacology 2015 - https://www.bps.ac.uk/news-events/future-scientific-meetings/2015/pharmacology-2015
- published: 17 Feb 2016
- views: 81
¿Cómo crecer en una empresa? Entrevista a Sofía Videla, HR Director AstraZeneca
- Order: Reorder
- Duration: 20:16
- Updated: 11 Nov 2015
- views: 364
¿De quién es la responsabilidad por el desarrollo profesional?¿Qué es más importante: crecer o aprender? Entrevista a Sofía Videla, Directora de RRHH de AstraZe...
¿De quién es la responsabilidad por el desarrollo profesional?¿Qué es más importante: crecer o aprender? Entrevista a Sofía Videla, Directora de RRHH de AstraZeneca
wn.com/¿Cómo Crecer En Una Empresa Entrevista A Sofía Videla, Hr Director Astrazeneca
¿De quién es la responsabilidad por el desarrollo profesional?¿Qué es más importante: crecer o aprender? Entrevista a Sofía Videla, Directora de RRHH de AstraZeneca
- published: 11 Nov 2015
- views: 364
Professor Sussan Nourshargh, AstraZeneca Women in Pharmacology Lecture 2014
- Order: Reorder
- Duration: 57:01
- Updated: 05 Feb 2015
- views: 312
Professor Sussan Nourshargh, Queen Mary University of London, delivered the AstraZeneca Women in Pharmacology Prize Lecture 2014: Breaching barriers: Junctures ...
Professor Sussan Nourshargh, Queen Mary University of London, delivered the AstraZeneca Women in Pharmacology Prize Lecture 2014: Breaching barriers: Junctures and junctions in inflammation at Pharmacology 2014
wn.com/Professor Sussan Nourshargh, Astrazeneca Women In Pharmacology Lecture 2014
Professor Sussan Nourshargh, Queen Mary University of London, delivered the AstraZeneca Women in Pharmacology Prize Lecture 2014: Breaching barriers: Junctures and junctions in inflammation at Pharmacology 2014
- published: 05 Feb 2015
- views: 312
OMXS30 SP500 Kinnevik AstraZeneca Husqvarna.avi
- Order: Reorder
- Duration: 24:42
- Updated: 29 Feb 2012
- views: 1210
De amerikanska börserna tuffar på och måndagens positiva reversalformation stärkte köparna under gårdagen. Även om uppgångarna var måttliga på Dow Jones och S&P;...
De amerikanska börserna tuffar på och måndagens positiva reversalformation stärkte köparna under gårdagen. Även om uppgångarna var måttliga på Dow Jones och S&P; 500 steg Nasdaq desto mer (tilltagande riskaptit). DJIA stängde igår över magiska 13.000 och S&P; 500 tog sig över 1371 som var taket för den motståndsnivå jag bevakat under några veckor. På ovansidan bevakar jag nu 1385-1396 från början av 2008 och därefter 1440 från den 19 maj 2008. På nedsidan bevakar jag utbrottsnivån 1371 följt av den korta sentimentnivån som MA-20 ger oss vid 1350. Därefter är det stödet vid 1300 följt av golvet i den stigande kanalen som inför dagen noteras kring 1277 som är intressant.
OMXS30 var i måndags nere och testade 20-dagars medelvärde för andra gången sedan den 20 december. Även denna gång stod medelvärdet pall och stärkte riskaptiten inför tisdagen. Gårdagens stängning ovanför 1100-nivån är positivt och nu bevakar jag först 1113 men framförallt blir det spännande att se om de senaste 12 årens fallande motståndslinje vid 1050 kommer att testas av och hur det går. På nedsidan hittar vi den första kritiska nivån vid 1085.
wn.com/Omxs30 Sp500 Kinnevik Astrazeneca Husqvarna.Avi
De amerikanska börserna tuffar på och måndagens positiva reversalformation stärkte köparna under gårdagen. Även om uppgångarna var måttliga på Dow Jones och S&P; 500 steg Nasdaq desto mer (tilltagande riskaptit). DJIA stängde igår över magiska 13.000 och S&P; 500 tog sig över 1371 som var taket för den motståndsnivå jag bevakat under några veckor. På ovansidan bevakar jag nu 1385-1396 från början av 2008 och därefter 1440 från den 19 maj 2008. På nedsidan bevakar jag utbrottsnivån 1371 följt av den korta sentimentnivån som MA-20 ger oss vid 1350. Därefter är det stödet vid 1300 följt av golvet i den stigande kanalen som inför dagen noteras kring 1277 som är intressant.
OMXS30 var i måndags nere och testade 20-dagars medelvärde för andra gången sedan den 20 december. Även denna gång stod medelvärdet pall och stärkte riskaptiten inför tisdagen. Gårdagens stängning ovanför 1100-nivån är positivt och nu bevakar jag först 1113 men framförallt blir det spännande att se om de senaste 12 årens fallande motståndslinje vid 1050 kommer att testas av och hur det går. På nedsidan hittar vi den första kritiska nivån vid 1085.
- published: 29 Feb 2012
- views: 1210
Professor Julia Buckingham, AstraZeneca Women in Pharmacology Prize Lecture 2009
- Order: Reorder
- Duration: 36:43
- Updated: 11 Jun 2015
- views: 49
Professor Julia Buckingham delivers the AstraZeneca Women in Pharmacology Prize Lecture 2009: Stress, laughter and a following wind.
Professor Julia Buckingham delivers the AstraZeneca Women in Pharmacology Prize Lecture 2009: Stress, laughter and a following wind.
wn.com/Professor Julia Buckingham, Astrazeneca Women In Pharmacology Prize Lecture 2009
Professor Julia Buckingham delivers the AstraZeneca Women in Pharmacology Prize Lecture 2009: Stress, laughter and a following wind.
- published: 11 Jun 2015
- views: 49
FIPH Account 2014 05 16 Pfizer & AstraZeneca
- Order: Reorder
- Duration: 22:05
- Updated: 18 May 2014
- views: 643
FIPH Account. Inversión Fundamental en Industria Farmacéutica y sector Health. Información e inversión bursatil, opiniones y formación continuada.
FIPH Account...
FIPH Account. Inversión Fundamental en Industria Farmacéutica y sector Health. Información e inversión bursatil, opiniones y formación continuada.
FIPH Account. Investment by Fundamental Analysis in pharmaceutical industry and Sector Health. Information and stock, opinions and training investmnet.
wn.com/Fiph Account 2014 05 16 Pfizer Astrazeneca
FIPH Account. Inversión Fundamental en Industria Farmacéutica y sector Health. Información e inversión bursatil, opiniones y formación continuada.
FIPH Account. Investment by Fundamental Analysis in pharmaceutical industry and Sector Health. Information and stock, opinions and training investmnet.
- published: 18 May 2014
- views: 643
close fullscreen
- Playlist
- Chat
close fullscreen
- Playlist
- Chat
3:46
The AstraZeneca story
Hear from our employees about AstraZeneca -- who we are, what we do and how we do it. Read...
published: 15 Sep 2011
The AstraZeneca story
The AstraZeneca story
- Report rights infringement
- published: 15 Sep 2011
- views: 24766
4:53
AstraZeneca Graduate Programme
Learn from AstraZeneca’s students about the exciting opportunities our graduate programmes...
published: 16 Sep 2015
AstraZeneca Graduate Programme
AstraZeneca Graduate Programme
- Report rights infringement
- published: 16 Sep 2015
- views: 1460
2:56
AstraZeneca Employees use Box to Drive Change through Innovation
Listen to David Smoley, Chief Information Officer, AstraZeneca discuss how Box has enabled...
published: 15 Sep 2015
AstraZeneca Employees use Box to Drive Change through Innovation
AstraZeneca Employees use Box to Drive Change through Innovation
- Report rights infringement
- published: 15 Sep 2015
- views: 2584
2:17
Astrazeneca Commercial 2016 Super Bowl Commercial
Astrazeneca Commercial 2016 Super Bowl Commercial. In this Super Bowl 50 commercial, a man...
published: 08 Feb 2016
Astrazeneca Commercial 2016 Super Bowl Commercial
Astrazeneca Commercial 2016 Super Bowl Commercial
- Report rights infringement
- published: 08 Feb 2016
- views: 1605
1:32
AstraZeneca and MedImmune: Our Purpose
We push the boundaries of science to deliver life-changing medicines.
published: 11 Dec 2014
AstraZeneca and MedImmune: Our Purpose
AstraZeneca and MedImmune: Our Purpose
- Report rights infringement
- published: 11 Dec 2014
- views: 6748
1:01
AstraZeneca reveals designs for new Global R&D; Centre and Corporate Headquarters in Cambridge, UK
AstraZeneca today revealed the proposed designs for its new Global R&D; Centre and Corporat...
published: 18 Jul 2014
AstraZeneca reveals designs for new Global R&D; Centre and Corporate Headquarters in Cambridge, UK
AstraZeneca reveals designs for new Global R&D; Centre and Corporate Headquarters in Cambridge, UK
- Report rights infringement
- published: 18 Jul 2014
- views: 10262
11:53
AstraZeneca - exclusive interview
Find out about the outlook for dividends, its drug pipeline and much more.
published: 30 Oct 2015
AstraZeneca - exclusive interview
AstraZeneca - exclusive interview
- Report rights infringement
- published: 30 Oct 2015
- views: 2339
4:01
Unique ABB robot solution increases throughput at AstraZeneca Australia
AstraZeneca Australia, is now relying on ABB robot technology to pack and palletise asthma...
published: 21 Dec 2015
Unique ABB robot solution increases throughput at AstraZeneca Australia
Unique ABB robot solution increases throughput at AstraZeneca Australia
- Report rights infringement
- published: 21 Dec 2015
- views: 2267
3:56
Employee Recognition at AstraZeneca
When leading global pharmaceutical company AstraZeneca decided to take a fresh look at wha...
published: 23 Feb 2014
Employee Recognition at AstraZeneca
Employee Recognition at AstraZeneca
- Report rights infringement
- published: 23 Feb 2014
- views: 2425
3:45
Dapo Ajayi - AstraZeneca Chief Procurement Officer
Watch to find out what attracted Dapo Ajayi, Chief Procurement Officer at AstraZeneca to h...
published: 19 Nov 2014
Dapo Ajayi - AstraZeneca Chief Procurement Officer
Dapo Ajayi - AstraZeneca Chief Procurement Officer
- Report rights infringement
- published: 19 Nov 2014
- views: 2918
close fullscreen
- Playlist
- Chat
0:50
Интерактивный сенсорный стол для AstraZeneca
С помощью игровых механик и трехмерной графики мы наглядно продемонстрировали преимущества...
published: 21 Jun 2016
Интерактивный сенсорный стол для AstraZeneca
Интерактивный сенсорный стол для AstraZeneca
- Report rights infringement
- published: 21 Jun 2016
- views: 17
1:19
AstraZeneca CI360 (Competitive Intelligence 360) Wins Bio-IT World 2016 Best Practice Award
AstraZeneca CI360 (Competitive Intelligence 360) Wins Bio-IT World 2016 Best Practice Awar...
published: 20 Jun 2016
AstraZeneca CI360 (Competitive Intelligence 360) Wins Bio-IT World 2016 Best Practice Award
AstraZeneca CI360 (Competitive Intelligence 360) Wins Bio-IT World 2016 Best Practice Award
- Report rights infringement
- published: 20 Jun 2016
- views: 2
5:02
AstraZeneca Presents Full Slate of Studies at ADA
With more than 60 presentations at the American Diabetes Association's meeting AstraZeneca...
published: 17 Jun 2016
AstraZeneca Presents Full Slate of Studies at ADA
AstraZeneca Presents Full Slate of Studies at ADA
- Report rights infringement
- published: 17 Jun 2016
- views: 7
0:46
Bourse - Action AstraZeneca, rebond anticipé - IG 16.06.2016
Suivez IG sur les réseaux sociaux :
- Twitter : https://twitter.com/IG_France_
- Faceboo...
published: 16 Jun 2016
Bourse - Action AstraZeneca, rebond anticipé - IG 16.06.2016
Bourse - Action AstraZeneca, rebond anticipé - IG 16.06.2016
- Report rights infringement
- published: 16 Jun 2016
- views: 10
2:45
AstraZeneca | 'What Science Can Do'
We worked directly with AstraZeneca to produce a series of award winning content for their...
published: 13 Jun 2016
AstraZeneca | 'What Science Can Do'
AstraZeneca | 'What Science Can Do'
- Report rights infringement
- published: 13 Jun 2016
- views: 3
8:19
Aspen, AstraZeneca ink R7BN deal
Aspen CEO Stephen Saad speaks to Alishia Seckam and Stephen Gunnion about the group’s R7 b...
published: 10 Jun 2016
Aspen, AstraZeneca ink R7BN deal
Aspen, AstraZeneca ink R7BN deal
- Report rights infringement
- published: 10 Jun 2016
- views: 82
1:03
Pfizer and AstraZeneca: Marketing an Acquisition (A) Case Solutions
http://www.thecasesolutions.com/
This case is about Pfizer and AstraZeneca: Marketing an ...
published: 09 Jun 2016
Pfizer and AstraZeneca: Marketing an Acquisition (A) Case Solutions
Pfizer and AstraZeneca: Marketing an Acquisition (A) Case Solutions
- Report rights infringement
- published: 09 Jun 2016
- views: 1
2:10
Tshirt review -LAST CHANCE - I CANT KEEP CALM, I WORK AT ASTRAZENECA PHARMACEUTICALS
LAST CHANCE - I CANT KEEP CALM, I WORK AT ASTRAZENECA PHARMACEUTICALS
CLICK HERE TO GET IT...
published: 08 Jun 2016
Tshirt review -LAST CHANCE - I CANT KEEP CALM, I WORK AT ASTRAZENECA PHARMACEUTICALS
3:25
AstraZeneca at ASCO16
AstraZeneca's Susan Galbraith, head of the oncology innovative medicines unit talks about ...
published: 06 Jun 2016
AstraZeneca at ASCO16
AstraZeneca at ASCO16
- Report rights infringement
- published: 06 Jun 2016
- views: 11
5:01
The Delaware Way AstraZeneca Billion Dollar Payroll Cuts
John Boyd Jr. is on to talk about Delaware's big name, AstraZeneca, and the Billion Dollar...
published: 06 Jun 2016
The Delaware Way AstraZeneca Billion Dollar Payroll Cuts
close fullscreen
- Playlist
- Chat
47:16
Decision Making in Early Clinical Development - Paul Frewer, AstraZeneca
East® User Group Meeting 2016 Featured Presentation
Paul Frewer, from the AZ Early Clinica...
published: 27 Mar 2016
Decision Making in Early Clinical Development - Paul Frewer, AstraZeneca
Decision Making in Early Clinical Development - Paul Frewer, AstraZeneca
- Report rights infringement
- published: 27 Mar 2016
- views: 123
49:24
Jay Greenspan Keynote Speech at AstraZeneca Global Safety Awards Banquet
Jay Greenspan Keynote Speech at AstraZeneca Global Engineering Americas Contractor Safety ...
published: 25 May 2016
Jay Greenspan Keynote Speech at AstraZeneca Global Safety Awards Banquet
Jay Greenspan Keynote Speech at AstraZeneca Global Safety Awards Banquet
- Report rights infringement
- published: 25 May 2016
- views: 99
71:30
GuruTalk with Mr.Pankaj Gursahani, Director - Sales Training, AstraZeneca India Pharma Ltd.
The Business Code of Conduct - Join AVAGMAH Online Schools ongoing GuruTalk series to lear...
published: 22 Oct 2013
GuruTalk with Mr.Pankaj Gursahani, Director - Sales Training, AstraZeneca India Pharma Ltd.
GuruTalk with Mr.Pankaj Gursahani, Director - Sales Training, AstraZeneca India Pharma Ltd.
- Report rights infringement
- published: 22 Oct 2013
- views: 1265
29:38
AstraZeneca BioVentureHub Mölndal - Life Science-dagen 2016
AstraZeneca BioVentureHub i Mölndal presenteras av Magnus Björsne.
Life Science-dagen ano...
published: 12 Mar 2016
AstraZeneca BioVentureHub Mölndal - Life Science-dagen 2016
AstraZeneca BioVentureHub Mölndal - Life Science-dagen 2016
- Report rights infringement
- published: 12 Mar 2016
- views: 34
40:55
Professor Jackie Hunter: AstraZeneca Women in Pharmacology Prize
Professor Jackie Hunter from the Biotechnology and Biological Sciences Research Council, U...
published: 17 Feb 2016
Professor Jackie Hunter: AstraZeneca Women in Pharmacology Prize
Professor Jackie Hunter: AstraZeneca Women in Pharmacology Prize
- Report rights infringement
- published: 17 Feb 2016
- views: 81
20:16
¿Cómo crecer en una empresa? Entrevista a Sofía Videla, HR Director AstraZeneca
¿De quién es la responsabilidad por el desarrollo profesional?¿Qué es más importante: crec...
published: 11 Nov 2015
¿Cómo crecer en una empresa? Entrevista a Sofía Videla, HR Director AstraZeneca
¿Cómo crecer en una empresa? Entrevista a Sofía Videla, HR Director AstraZeneca
- Report rights infringement
- published: 11 Nov 2015
- views: 364
57:01
Professor Sussan Nourshargh, AstraZeneca Women in Pharmacology Lecture 2014
Professor Sussan Nourshargh, Queen Mary University of London, delivered the AstraZeneca Wo...
published: 05 Feb 2015
Professor Sussan Nourshargh, AstraZeneca Women in Pharmacology Lecture 2014
Professor Sussan Nourshargh, AstraZeneca Women in Pharmacology Lecture 2014
- Report rights infringement
- published: 05 Feb 2015
- views: 312
24:42
OMXS30 SP500 Kinnevik AstraZeneca Husqvarna.avi
De amerikanska börserna tuffar på och måndagens positiva reversalformation stärkte köparna...
published: 29 Feb 2012
OMXS30 SP500 Kinnevik AstraZeneca Husqvarna.avi
OMXS30 SP500 Kinnevik AstraZeneca Husqvarna.avi
- Report rights infringement
- published: 29 Feb 2012
- views: 1210
36:43
Professor Julia Buckingham, AstraZeneca Women in Pharmacology Prize Lecture 2009
Professor Julia Buckingham delivers the AstraZeneca Women in Pharmacology Prize Lecture 20...
published: 11 Jun 2015
Professor Julia Buckingham, AstraZeneca Women in Pharmacology Prize Lecture 2009
Professor Julia Buckingham, AstraZeneca Women in Pharmacology Prize Lecture 2009
- Report rights infringement
- published: 11 Jun 2015
- views: 49
22:05
FIPH Account 2014 05 16 Pfizer & AstraZeneca
FIPH Account. Inversión Fundamental en Industria Farmacéutica y sector Health. Información...
published: 18 May 2014
FIPH Account 2014 05 16 Pfizer & AstraZeneca
FIPH Account 2014 05 16 Pfizer & AstraZeneca
- Report rights infringement
- published: 18 May 2014
- views: 643
Decision Making in Early Clinical Development - Pa...
Jay Greenspan Keynote Speech at AstraZeneca Global...
GuruTalk with Mr.Pankaj Gursahani, Director - Sale...
AstraZeneca BioVentureHub Mölndal - Life Science-...
Professor Jackie Hunter: AstraZeneca Women in Phar...
¿Cómo crecer en una empresa? Entrevista a Sofía Vi...
Professor Sussan Nourshargh, AstraZeneca Women in ...
OMXS30 SP500 Kinnevik AstraZeneca Husqvarna.avi...
Professor Julia Buckingham, AstraZeneca Women in P...
FIPH Account 2014 05 16 Pfizer & AstraZeneca...
photo: US Navy / Mass Communication Specialist 2nd Class Eric C. Tretter
[VIDEO]: Texas Woman Awakens From Surgery With British Accent
Edit WorldNews.com 23 Jun 2016
Lisa Alamia, a mother of three, was scheduled for surgery to fix an overbite in December 2015. The native-born Texan, who claims to have never left the U.S. with the exception of a trip to Mexico several years ago, had successful surgery and woke up with an unexpected side effect – a British accent, ABC News reported Thursday. Her doctor thought swelling was causing the condition ... – WN.com, Jack Durschlag. ....
photo: AP / Chuck Burton
Is Donald Trump right about Hillary Clinton?
Edit CNN 23 Jun 2016
(CNN)Donald Trump's much-anticipated speech attacking Hillary Clinton Wednesday seemed more designed to reassure the candidate's Republican base than to broaden his appeal to independents or Democrats ... For example, it's one thing to question the Obama administration's foreign policy, and quite another to leap to Trump's overheated conclusion ... Her decisions spread death, destruction and terrorism everywhere she touched.". JUST WATCHED ... ....
photo: AP / Daniel Maurer
[VIDEO]: Gunman Killed After Allegedly Taking Hostages At German Cinema
Edit WorldNews.com 23 Jun 2016
Multiple media reports say a masked gunman who entered a cinema complex in the western German city of Viernheim in the state of Hessen and reportedly held hostages has been killed.State Interior Minister Peter Beuth told parliament police stormed the Knopolis complex near Frankfurt after reports of shots fired shot the as-yet unidentified gunman dead, the Belfast Telegraph reported....
photo: AP / Sang Tan
As Polls Close, UKIP's Nigel Farage Concedes Defeat For Brexit Referendum
Edit WorldNews.com 23 Jun 2016
Just minutes after polls closed in the landmark referendum on Britain’s European Union membership Thursday night, Nigel Farage, leader of the Euroskeptic, right-wing United Kingdom Independence Party (UKIP) appeared to concede defeat, Newsweek reported. In a statement issued just minutes after the 10 p.m. polls closing, Farage said it “looks like Remain will edge it” in what he described as an “extraordinary campaign.”....
photo: WN ALI HASSAN
Orlando Nightclub Shooter Buried In Muslim Cemetery
Edit WorldNews.com 23 Jun 2016« back to news headlines
Teva Settles Patent Litigation with AstraZeneca Allowing Teva to Commercialize Its Generic Version of Byetta® ...
Edit Business Wire 23 Jun 2016
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceuticals USA, Inc., (NYSE and TASE.TEVA) today announced that they have settled the patent litigation with AstraZeneca Pharmaceuticals LP, AstraZeneca AB and Amylin Pharmaceuticals, LLC (AstraZeneca) relating to AstraZeneca’s US Patent Nos ... license agreement with AstraZeneca, pursuant to which AstraZeneca ......
CDC Advises Against Using AstraZeneca’s FluMist Next Season
Edit Bloomberg 23 Jun 2016
Centers for Disease Control and Prevention advised against using AstraZeneca Plc’s FluMist nasal vaccine in the upcoming flu season after a panel found it wasn’t effective enough in the last three influenza seasons....
Teva, AstraZeneca settle patent dispute over multimillion-dollar drug
Edit Business Journal 23 Jun 2016
Teva Pharmaceuticals USA Inc. said Thursday it has settled patent litigation with AstraZeneca Pharmaceuticals and Amylin Pharmaceuticals that involved the prescription medicine Byetta. Byetta is an injectable drug used to improve blood sugar control in adults with type 2 diabetes. The drug generated revenues of $316 million for AstraZeneca in 2015. Under the terms of the settlement, AstraZeneca (NYSE. AZN) granted a license to Teva (NYSE....
AstraZeneca, Teva Resolve Their Patent Row Over Diabetes Product
Edit The Street 23 Jun 2016
AstraZeneca (AZN) and Teva Pharmaceuticals USA (TEVA) have settled their patent dispute over Byetta (exenatide injection), an injectable product for treatment of type 2 diabetes, according to a June 23 announcement. Under the settlement and license agreement, AstraZeneca has granted Teva a license to manufacture and commercialize the generic version of Byetta....
3 buys whatever the EU referendum result: AstraZeneca plc, YouGov plc and Cobham plc
Edit The Motley Fool 23 Jun 2016
One such is AstraZeneca (LSE ... And on the patent front it appears to be making strong progress with its acquisition strategy improving AstraZeneca’s treatment pipeline so that it’s on track to return to positive earnings growth over the medium term. Furthermore, AstraZeneca is unlikely to slow down its pace of acquisitions, with the company having excellent cash flow, which affords it tremendous financial firepower....
BRIEF-Teva settles patent litigation with AstraZeneca
Edit Reuters 23 Jun 2016
* Teva settles patent litigation with AstraZeneca allowing Teva to commercialize its generic version of Byetta (Exenatide injection) in the United States ....
U.S. spurns AstraZeneca's nasal spray flu vaccine as ineffective
Edit Philadelphia Daily News 23 Jun 2016CDC says flu mist not effective for children
Edit Philadelphia Daily News 23 Jun 2016
AstraZeneca, with North American headquarters in Wilmington, said it would take an $80 million inventory write-down as a result of the decision. AstraZeneca said ......
- 1
- 2
- 3
- 4
- 5
- Next page »
